Ew Healthcare Partners Fund 2, L.P.'s Form 4 filing
TELA Bio, Inc. (TELA) ยท filed Feb 16, 2024
- Accession no.
- 0000950170-24-016357
- Filed
- Feb 16, 2024, 4:10 PM ET
- Trade date
- Apr 1, 2020-Jul 14, 2022
- Filing delay
- 1,416 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 27 non-derivative transactions. Open-market purchases total $3.04M. It was filed 1416 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ew Healthcare Partners Fund 2, L.P.CIK 0001746777 | 10% Owner, Other: See Remarks |
| Ew Healthcare Partners Fund 2-A, L.P.CIK 0001746779 | 10% Owner, Other: See Remarks |
| EW Healthcare Partners Fund 2 GP, L.P.CIK 0001793943 | 10% Owner, Other: See Remarks |
| EW Healthcare Partners Fund 2-UGP, LLCCIK 0001793948 | 10% Owner, Other: See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +15,000 | $7.47F1 | +$112,050 | 1,169,231 | Indirect | |
| Apr 2, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +15,000 | $8.01 | +$120,150 | 1,184,231 | Indirect | |
| Apr 3, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +9,634 | $8.01F4 | +$77,168.34 | 1,193,865 | Indirect | |
| Apr 6, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +17,866 | $8.10F6 | +$144,714.6 | 1,211,731 | Indirect | |
| Apr 7, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +20,000 | $8.20F8 | +$164,000 | 1,231,731 | Indirect | |
| Apr 8, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +15,000 | $8.37F10 | +$125,550 | 1,246,731 | Indirect | |
| Apr 9, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +25,000 | $8.47F12 | +$211,750 | 1,271,731 | Indirect | |
| Apr 13, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +10,000 | $7.96F14 | +$79,600 | 1,281,731 | Indirect | |
| Apr 14, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +15,000 | $8.07F16 | +$121,050 | 1,296,731 | Indirect | |
| Apr 15, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +12,500 | $7.99F18 | +$99,875 | 1,309,231 | Indirect | |
| Apr 16, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +17,500 | $8.00F20 | +$140,000 | 1,326,731 | Indirect | |
| Apr 17, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +25,000 | $8.25F22 | +$206,250 | 1,351,731 | Indirect | |
| Apr 20, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +7,000 | $8.06F24 | +$56,420 | 1,358,731 | Indirect | |
| Apr 21, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +3,037 | $8.32 | +$25,267.84 | 1,361,768 | Indirect | |
| Apr 22, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +10,000 | $9.14F27 | +$91,400 | 1,371,768 | Indirect | |
| Apr 23, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +15,000 | $9.98F29 | +$149,700 | 1,386,768 | Indirect | |
| Apr 28, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +5,000 | $9.48 | +$47,400 | 1,391,768 | Indirect | |
| Jul 28, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +10,000 | $12.48 | +$124,800 | 1,401,768 | Indirect | |
| Jul 29, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +12,600 | $12.39F33 | +$156,114 | 1,414,368 | Indirect | |
| Jul 30, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +7,400 | $12.22 | +$90,428 | 1,421,768 | Indirect | |
| Jul 31, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +31,825 | $11.86F36 | +$377,444.5 | 1,453,593 | Indirect | |
| Aug 3, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,400 | $11.86 | +$16,604 | 1,454,993 | Indirect | |
| Aug 4, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +10,200 | $12.72 | +$129,744 | 1,465,193 | Indirect | |
| Aug 11, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +821 | $12.95 | +$10,631.95 | 1,466,014 | Indirect | |
| Aug 14, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +9,179 | $12.95 | +$118,868.05 | 1,475,193 | Indirect | |
| Aug 28, 2020 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +100 | $12.85 | +$1,285 | 1,475,293 | Indirect | |
| Jul 14, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +5,000 | $8.01 | +$40,050 | 3,610,709 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.56 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F6
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.16 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F8
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.98 to $8.39 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F10
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.36 to $8.38 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F12
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.35 to $8.58 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F14
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.93 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F16
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.09 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F18
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.97 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F20
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.99 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F22
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.18 to $8.29 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F24
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.14 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F27
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.08 to $9.19 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F29
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $9.99 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F33
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.34 to $12.40 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F36
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $12.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
The amounts reported in Column 5 of Table I reflect the aggregate number of shares of common stock held by the reporting persons as of the date of each respective transaction. As of the date of this filing, the reporting persons owned an aggregate 4,110,709 shares (the "Shares"), 1,615,368 of which are held by EW Fund 2 and 2,495,341 of which are held by EW Fund 2-A. EW Healthcare Partners Fund 2-GP, L.P. ("EW Funds GP"), is the general partner of each of the EW Funds. EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the Shares. The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the '"Managers"') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.